Loading...
XHKG
2407
, Last price  
HKD
Name

Gaush Meditech Ltd

Chart & performance

D1W1MN
XHKG:2407 chart
P/E
—
P/S
—
EPS
0.65
Vol. 1Y
—
Shs. 5Y
6.61%
Rev. 5Y
7.49%
Div Yld LY
—
Div Yld TTM
—
Revenues
1.38b
-3.36%
1,106,655,000962,075,0001,298,218,0001,253,785,0001,406,238,0001,428,397,0001,380,354,000
Net income
96m
+4.11%
-37,041,00099,367,000-190,447,000-349,619,000173,523,00092,394,00096,189,000
CFO
144m
+33.82%
171,064,000130,001,000164,486,000234,422,000249,038,000107,783,000144,233,000
Dividend
Jun 23, 20250.3 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Gaush Meditech Ltd., alongside its affiliates, is engaged in the global research, development, manufacturing, and sale of specialized medical devices for ophthalmology, serving markets both within the People's Republic of China and internationally. The company's operations are divided into four main divisions: Proprietary Products, Distribution, Technical Services, and Other Business Ventures. Its advanced ophthalmic instruments are crucial for the diagnosis, treatment, and surgical intervention of a broad spectrum of eye conditions, including vitreoretinal disorders, cataracts, glaucoma, refractive errors, ocular surface diseases, and issues in optometry and pediatric ophthalmology. The Proprietary Products division focuses on creating and producing its own line of surgical apparatus, accompanying software, intraocular lenses, and equipment for diagnosing and treating eye ailments, along with their associated consumables. Conversely, the Distribution division is responsible for selling diagnostic devices, equipment for ocular fundus examination, surgical and treatment instruments, and related consumables. The Technical Services segment provides essential support, covering warranty services, maintenance, and the supply of post-sales consumables. Lastly, the Other Business Ventures division handles equipment rental, agent registration services, and the licensing of intellectual property. Gaush Meditech Ltd. reaches its clientele—comprising public and private hospitals, among other customers—through both direct sales and a network of distributors. The company was established in 1998 and has its corporate headquarters situated in Beijing, China.
IPO date
Dec 12, 2022
Employees
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT